CAS RN: 32385-11-8

Sisomicin

Product Availability

Choose a grade to view its available package options.

3 package records3 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250622 100mg In stock Shanghai Inquiry
Batchno.20250613 1g In stock Shanghai Inquiry
Batchno.20250710 250mg In stock Shanghai, Shenzhen Inquiry
  • Product code: SSC-137949
GET A QUOTE
Historical Factory Record

Historical Supply Reference

This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.

  • Pack sizes on record: 1g
  • Available purity: ≥95%
  • Inventory rows with stock: 0
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Reference Pack Sizes

Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 32385-11-8
Pack Size Recorded Purity Available Qty Ship From Inquiry
1g ≥95% 0 Out of Stock Shanghai Inquiry

32385-11-8 / 2-[4,6-diamino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol

Standard CAS: 32385-11-8 Multi CAS: Yes

Basic Information

CAS
32385-11-8
Multi CAS
Yes
Molecular Formula
C19H37N5O7
Molecular Weight
447.500000
Exact Mass
447.269299
InChI
InChI=1S/C19H37N5O7/c1-19(27)7-28-18(13(26)16(19)24-2)31-15-11(23)5-10(22)14(12(15)25)30-17-9(21)4-3-8(6-20)29-17/h3,9-18,24-27H,4-7,20-23H2,1-2H3/t9-,10+,11-,12+,13-,14-,15+,16-,17-,18-,19+/m1/s1
InChIKey
URWAJWIAIPFPJE-YFMIWBNJSA-N

Computed Properties

Structural Parameters

Heavy atom count
31
Fraction Csp3
0.89
Rotatable bonds
6
H-bond acceptors
12
H-bond donors
8
Molar refractivity
110.14
TPSA
213.72

LogP / Solubility

WLOGP
-3.85
MLOGP
-3.36
XLogP3
-5.1
Consensus LogP
-4.1
Log S (ESOL)
0.21
Class (ESOL)
Highly soluble
Log S (Ali)
-0.45
Class (Ali)
Very soluble
Log S (SILICOS-IT)
-0.09
Class (SILICOS-IT)
Very soluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-8.18

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Leadlikeness
No
Synthetic Accessibility
8

Get In Touch

Contact Us